This is a preview of subscription content
Access options
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.


References
Nosengo, N. Nature 534, 314–316 (2016).
Hay, M., Thomas, D.W., Craighead, J.L., Economides, C. & Rosenthal, J. Nat. Biotechnol. 32, 40–51 (2014).
Goldstein, I. et al. N. Engl. J. Med. 338, 1397–1404 (1998).
Palumbo, A. et al. Blood 111, 3968–3977 (2008).
Lamb, J. et al. Science 313, 1929–1935 (2006).
Yu, C. et al. Nat. Biotechnol. 34, 419–423 (2016).
Huang, R. et al. Sci. Transl. Med. 3, 80ps16 (2011).
Law, V. et al. Nucleic Acids Res. 42, D1091–D1097 (2014).
Qin, C. et al. Nucleic Acids Res. 42, D1118–D1123 (2014).
Mi, H. et al. Nucleic Acids Res. 33, D284–D288 (2005).
Blaxill, Z., Holland-Crimmin, S. & Lifely, R. J. Biomol. Screen. 14, 547–556 (2009).
Lawrence, M.S. et al. Nature 505, 495–501 (2014).
Heller, S.R., McNaught, A., Pletnev, I., Stein, S. & Tchekhovskoi, D. J. Cheminform. 7, 23 (2015).
Acknowledgements
We thank the members of the Broad Institute Compound Management team for their invaluable assistance. We also thank C. Yu, J. Boehm, N. Tolliday, J. Athanasopoulos, J. Rosains, S. Loranger, and A. Burgin for helpful scientific discussions. This work was supported in part by NIH LINCS Program grants 3U54 HG006093 (T.R.G. and A.S.), U54 HL127366 (T.R.G. and A.S.), and U54 HG008699 (T.R.G. and A.S.). Additional support was provided by the Howard Hughes Medical Institute (T.R.G.), NIH training grant T32 CA009172 (S.M.C.), KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) Award KL2 TR001100 (S.M.C.), and the Conquer Cancer Foundation of ASCO Young Investigator Award (S.M.C.).
Author information
Authors and Affiliations
Contributions
S.M.C. and T.R.G. conceived the project, designed experiments, and wrote the paper with input from coauthors; A.V., S.E.J., P.M., and J.A.B. performed analytical chemistry and compound management activities; P.M., J.A.B., and S.M.C. performed chemical-structure analysis; S.M.C., Z.L., J.E.H., R.N., and C.C.M. annotated drug properties; B.W. and M.K. designed the Drug Repurposing Hub web-portal interface and assisted with manuscript figures; J.G., J.A., and A.S. designed and implemented the hub database, interactive web platform, and data API.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Figures & Tables
Supplementary Figures 1–6 & Supplementary Tables 1–4 (PDF 13309 kb)
Rights and permissions
About this article
Cite this article
Corsello, S., Bittker, J., Liu, Z. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat Med 23, 405–408 (2017). https://doi.org/10.1038/nm.4306
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4306
Further reading
-
DrugShot: querying biomedical search terms to retrieve prioritized lists of small molecules
BMC Bioinformatics (2022)
-
Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy
Molecular Cancer (2022)
-
RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition
Nature Communications (2022)
-
Functional stratification of cancer drugs through integrated network similarity
npj Systems Biology and Applications (2022)
-
Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs
Scientific Reports (2022)